{
  "api": "assay-systems/v1",
  "key_tier": "none",
  "retrieved": "2026-10-16T04:24:31Z",
  "source": "Assay Systems register, https://assay-systems.com/register/",
  "access_notice": "On 15 November 2026, automated access to assay-systems.com closes. After that date, access is available only under a paid annual subscription contract. Contact: contact@assay-systems.com",
  "data": {
    "id": "ASY-CA-06HKOOV18R",
    "type": "grant",
    "country": "ca",
    "name": "STRESSMARQ BIOSCIENCES INC.: federal grants and contributions",
    "url": "https://assay-systems.com/register/ca/grants/r/stressmarq-biosciences-inc/",
    "summary": "13 federal grant and contribution agreements worth $1.2M with STRESSMARQ BIOSCIENCES INC., 2014–2026.",
    "figures": [
      {
        "label": "agreements",
        "value": 13,
        "unit": "count"
      },
      {
        "label": "value",
        "value": 1200000,
        "unit": "money",
        "currency": "CAD",
        "approximate": true,
        "display": "$1.2M"
      },
      {
        "label": "departments",
        "value": 1,
        "unit": "count"
      },
      {
        "label": "programs",
        "value": 4,
        "unit": "count"
      }
    ],
    "text": [
      "Development of a suite of proteins, antibodies, and assays for use in Parkinson’s Disease research and an antibody to treat the disease.",
      "This project will develop techniques to generate active, soluble oligomeric constructs of prion-like proteins relevant in neurological disease, including Tau, alpha synuclein and Abeta, using a variety of physical and chemical techniques.",
      "This project aims to generate materials that can be used in an protein-based amplification assay that can determine the presence of prion-like aggregates in biological samples.",
      "Stressmarq Biosciences Inc. Has developed a range of fibrilized and oligomeric protein preparations used in neurodegenerative disease research. The company aims to increase it's export of these to five key European territories.",
      "The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.",
      "The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.",
      "Stressmarq Biosciences Inc. Has developed a range of fibrilized and oligomeric protein preparations used in neurodegenerative disease research. The company aims to increase it's export of these to five key European territories.",
      "The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors."
    ],
    "records": [
      {
        "name": "grants and contributions register",
        "url": "https://assay-systems.com/register/ca/grants/"
      },
      {
        "name": "Victoria",
        "url": "https://assay-systems.com/register/ca/grants/riding/59041-victoria/"
      },
      {
        "name": "National Research Council Canada",
        "url": "https://assay-systems.com/register/ca/grants/department/national-research-council-canada/"
      }
    ],
    "assay_record": "ASY-CA-06HKOOV18R",
    "cite_as": "Assay Systems, \"STRESSMARQ BIOSCIENCES INC.: federal grants and contributions\", https://assay-systems.com/register/ca/grants/r/stressmarq-biosciences-inc/"
  }
}